Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Antipsychotic long-acting injections: prescribing practice in the UK.

Barnes TR, Shingleton-Smith A, Paton C.

Br J Psychiatry Suppl. 2009 Nov;52:S37-42. doi: 10.1192/bjp.195.52.s37.

PMID:
19880915
2.

Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.

Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A.

Schizophr Res. 2016 Dec;178(1-3):58-63. doi: 10.1016/j.schres.2016.09.014. Epub 2016 Sep 10.

PMID:
27624680
3.

Community treatment orders and antipsychotic long-acting injections.

Lambert TJ, Singh BS, Patel MX.

Br J Psychiatry Suppl. 2009 Nov;52:S57-62. doi: 10.1192/bjp.195.52.s57.

PMID:
19880919
4.

Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Taylor DM, Young CL, Mace S, Patel MX.

J Clin Psychiatry. 2004 Aug;65(8):1076-83.

PMID:
15323592
5.

A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.

Iyer S, Banks N, Roy MA, Tibbo P, Williams R, Manchanda R, Chue P, Malla A.

Can J Psychiatry. 2013 May;58(5 Suppl 1):23S-9S.

PMID:
23945064
6.

Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.

Doshi JA, Pettit AR, Stoddard JJ, Zummo J, Marcus SC.

J Clin Psychopharmacol. 2015 Aug;35(4):442-6. doi: 10.1097/JCP.0000000000000353.

PMID:
26075492
7.

Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.

Samalin L, Garnier M, Auclair C, Llorca PM.

Int J Mol Sci. 2016 Nov 19;17(11). pii: E1935.

8.

Explicit review of risperidone long-acting injection prescribing practice.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

J Clin Pharm Ther. 2011 Dec;36(6):651-63. doi: 10.1111/j.1365-2710.2010.01219.x. Epub 2010 Nov 5.

PMID:
22023342
9.
10.

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.

Barnes TR, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C.

Br J Psychiatry. 2012 Sep;201(3):221-6. doi: 10.1192/bjp.bp.111.107631. Epub 2012 Jul 12.

11.

Clinical guideline recommendations for antipsychotic long-acting injections.

Kane JM, Garcia-Ribera C.

Br J Psychiatry Suppl. 2009 Nov;52:S63-7. doi: 10.1192/bjp.195.52.s63. Review.

PMID:
19880920
12.
13.

Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.

Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A.

Acta Psychiatr Scand. 2017 May;135(5):429-438. doi: 10.1111/acps.12722. Epub 2017 Mar 23.

PMID:
28332704
14.

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Bachmann CJ, Lempp T, Glaeske G, Hoffmann F.

Dtsch Arztebl Int. 2014 Jan 17;111(3):25-34. doi: 10.3238/arztebl.2014.0025.

15.

Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.

Latimer EA, Naidu A, Moodie EE, Clark RE, Malla AK, Tamblyn R, Wynant W.

Psychiatr Serv. 2014 Oct;65(10):1210-7. doi: 10.1176/appi.ps.201300217.

PMID:
24981557
16.

Prescribing of antipsychotics in UK primary care: a cohort study.

Marston L, Nazareth I, Petersen I, Walters K, Osborn DP.

BMJ Open. 2014 Dec 18;4(12):e006135. doi: 10.1136/bmjopen-2014-006135.

17.

Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.

Dimitropoulos E, Drogemuller L, Wong K.

J Clin Psychopharmacol. 2017 Oct;37(5):605-608. doi: 10.1097/JCP.0000000000000755.

PMID:
28816923
18.

National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom.

Prah P, Petersen I, Nazareth I, Walters K, Osborn D.

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):161-9. doi: 10.1002/pds.2213. Epub 2011 Aug 19.

PMID:
21858898
19.

Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.

Rossi G, Frediani S, Rossi R, Rossi A.

BMC Psychiatry. 2012 Aug 21;12:122. doi: 10.1186/1471-244X-12-122. Review.

20.

Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.

Aggarwal NK, Sernyak MJ, Rosenheck RA.

J Clin Psychopharmacol. 2012 Jun;32(3):323-8. doi: 10.1097/JCP.0b013e31825244f6.

PMID:
22544006

Supplemental Content

Support Center